Finance

Lists
APLLTD:NSE
Alembic Pharmaceuticals Ltd
₹836.50
-0.73%
(-6.15) 1D
Jul 21, 3:30:03 PM GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for APLLTD...
Open
₹842.65
High
₹843.00
Low
₹830.55
Mkt. cap
164.43B
Avg. vol.
151.64K
Volume
46.22K
Dividend
1.43%
Quarterly dividend
₹3.00
Ex-dividend date
Jul 29, 2026
P/E ratio
24.37
52-wk high
₹1,038.00
52-wk low
₹635.80
EPS
₹34.33
Shares outstanding
188.50M
No. of employees
17K
Open
₹842.65
High
₹843.00
Low
₹830.55
Mkt. cap
164.43B
Avg. vol.
151.64K
Volume
46.22K
Dividend
1.43%
Quarterly dividend
₹3.00
Ex-dividend date
Jul 29, 2026
P/E ratio
24.37
52-wk high
₹1,038.00
52-wk low
₹635.80
EPS
₹34.33
Shares outstanding
188.50M
No. of employees
17K
News stories
From sources across the web
About Alembic Pharmaceuticals Ltd
CEO-
Employees17.2K
Founded1907
Headquarters-
SectorPharmaceutical industry
Website-
Next call in 13 days
Tue, Aug 4, 7:00 AM
Fiscal period
Q1 2027
EPS / Est. (INR)
- / ₹7.79
Revenue / Est. (INR)
- / 18.97B
Fiscal Q1 2027 earnings call
Waiting for the earnings call
At a glance: upcoming earnings
Insights from the latest news and reports
Previous reportsAll values in INR
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in INR
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
17.11B
19.10B
18.76B
18.48B
Cost of goods sold
4.07B
5.16B
5.29B
6.27B
Cost of revenue
4.07B
5.16B
5.29B
6.27B
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
4.23B
4.38B
4.33B
4.39B
Operating expense
10.96B
11.55B
11.34B
10.85B
Total operating expenses
15.03B
16.71B
16.63B
17.11B
Operating income
2.08B
2.40B
2.13B
1.36B
Other non operating income
65.00M
69.00M
154.90M
-285.60M
EBT including unusual items
1.90B
2.24B
1.61B
1.19B
EBT excluding unusual items
1.90B
2.24B
2.04B
1.37B
Income tax expense
364.80M
400.00M
295.40M
-829.00M
Effective tax rate
19.19%
17.88%
18.29%
-69.88%
Other operating expenses
5.99B
6.41B
6.21B
5.56B
Net income
1.54B
1.85B
1.33B
2.03B
Net profit margin
9.02%
9.67%
7.09%
10.97%
Earnings per share
7.85
9.40
8.51
11.57
Interest and investment income
-
-
-
8.60M
Interest expense
-235.20M
-242.30M
-233.10M
-225.60M
Net interest expenses
-235.20M
-242.30M
-233.10M
-217.00M
Depreciation and amortization charges
737.70M
760.70M
801.20M
885.90M
EBITDA
2.72B
3.15B
2.78B
2.12B
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Create a portfolio
Create a task
Deep Search
AI content may include mistakes. Learn more